ABSTRACT
The primary purpose of this study was to investigate the potential role of transient-evoked Otoacoustic emissions (TEOAEs) beyond screening for hearing impairment in different middle/inner ear disorders in 3-65 years age group. Because TEOAEs are present in ears with normal cochlear and middle ear function and typically are absent or reduced in ears with cochlear and/or middle ear disorders of even mild degree. This was a prospective study of four hundred cases. Out of these 364 cases were having problems related to otology and 36 were healthy volunteers who attended the department of otorhinolaryngology of our institute. All the cases were kept in different eight groups and then subjected to Otoacoustic emission testing with the 'GSI AUDIO screener' equipment installed in our ENT department. The data obtained in all groups were analyzed and conclusion was made. TEOAEs is a reliable, simple and cost effective screening technique for hearing disorders with sensitivity varying from 72 to 96.42 % among the study groups and 88 % in composite group comprising all study groups.
ABSTRACT
The aim of our study is to understand the concept of unified airway disease, to know the advantage of this concept in the diagnosis and treatment of allergic rhinitis, chronic rhino-sinusitis and asthma, to know its impact on practice of otolaryngologists, to motivate the otorhinolaryngologist to apply this concept in diagnosis and treatment. This article is based on our experience on (20 cases) chronic rhino-sinusitis and asthma, and observations and results from various literatures. Implement of the concept of unified airway disease and ability to translate its principles into successful diagnostic and treatment strategies can enhance the practice of otolaryngology. The end result is the potential for improved patient care. In our study 80% cases have reduced frequency of symptoms and all (100%) cases having improved night time symptoms thus the use of short-acting beta2 agonist to control the asthma symptoms decreases.
ABSTRACT
The purpose of our study was to determine the incidence of hearing loss and to describe the hearing impairment and the possible contributing factors, responsible for sensori neural hearing loss in chronic renal failure (CRF) patients. This was a prospective study carried out on 50 cases of CRF attending otorhinolaryngological services for hearing disturbance and on 50 healthy volunteers for control study, having the same inclusion criteria except (does not suffering with CRF) having normal renal function tests. These volunteers attended the ENT OPD, for oto-rhino-laryngological services but not for hearing problems. 14 (28%) out of 50 cases of CRF had sensori neural hearing loss of moderate to severe degree in the high frequency range which was bilateral and symmetrical, while in control group the incidence of sensorineural hearing loss was only 6%.
